Global Transcranial Magnetic Stimulation (TMS) Service Market Strategic Research Report

Scope of the Report

The global Transcranial Magnetic Stimulation (TMS) Service market size is predicted to grow from US$ 115 million in 2025 to US$ 165 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.

Transcranial magnetic stimulation (TMS) services are non-invasive brain stimulation treatments provided by hospitals, mental health institutions, neuromodulation centers, specialist clinics, or chain medical service platforms. Based on TMS equipment and standardized clinical treatment procedures, these services are offered to patients with mental and neurological disorders. TMS services focus on outpatient treatment services centered around TMS, rTMS, Deep TMS, iTBS, and accelerated TMS protocols. These services typically include patient screening, indication assessment, treatment target localization, motor threshold measurement, magnetic stimulation parameter setting, treatment execution, efficacy evaluation, maintenance therapy, and insurance/payment support.

From a demand structure perspective, treatment-resistant depression remains the largest revenue source for TMS (Therapeutic Treatment) services, while indications such as obsessive-compulsive disorder, anxiety and depression, smoking cessation, neurorehabilitation, and chronic pain represent growth potential. Medicare and commercial insurance coverage in the US are crucial foundations for increasing service penetration. In Europe, public and private insurance systems significantly impact accessibility, while the Chinese and Asian markets are more influenced by hospital department capabilities, physician awareness, patient out-of-pocket payment capacity, and the number of available devices. With iTBS and accelerated TMS shortening the duration of each treatment session, service providers can theoretically improve device turnover and revenue efficiency per site; however, their commercialization success still depends on indication approval, payment policies, and clinical acceptance. Future service growth will come not only from new treatment sites but also from increased utilization of existing sites and improved combination treatment pathways.

This report presents a comprehensive overview of the global Transcranial Magnetic Stimulation (TMS) Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Conventional rTMS
• iTBS
• cTBS
• Other

Segment by Pulse Mode

• Single-Pulse TMS
• Double-Pulse TMS (pTMS)

Segment by Pulse Frequency

• ＞1Hz
• ≤1Hz

Segment by Application

• Clinical Treatment
• Neurological Function Assessment
• Scientific Research Experiments
• Rehabilitation Training
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Transcranial Magnetic Stimulation (TMS) Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Clinical Treatment, Neurological Function Assessment, Scientific Research Experiments evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact